Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Discovery of ancient pleasure boat reveals Egypt's maritime history - 2Nigeria warns its citizens in South Africa to be cautious after march turns violent
- 3A 'rampaging lion' nebula roars to life in a stunning deep-space photo
- 4People can't get enough of this couple's Hallmark movie reviews. They don't know the painful backstory.
- 5Spanish police and soldiers track boars, reinforce farm security amid swine fever outbreak
- 10 Demonstrated Systems to Develop Your Internet based Business
- Toddler diagnosed with cancer makes remarkable recovery after aggressive treatment
- The many ways that baking is winter therapy. With a delicious ending
- Doomed SpaceX Starlink satellite photographed from orbit
- Instructions to Upgrade the Proficiency of Your Sunlight powered chargers
- Why is the Artemis 2 rocket launch different from all other rocket launches?
- ADHD drugs work, but not the way experts thought
- 'Tangled' live-action movie casts Teagan Croft and Milo Manheim as Rapunzel and Flynn
- Study reveals how fast weight returns after ending GLP-1 drugs
